Companies · Other Health Care

Hygea Holdings Corp.

Doral · Other Health Care

Diligence memoA one-page analyst read on Hygea Holdings Corp. — recommendation, valuation, rhythm, risks.
$10.1M
Total raised · real
6
Rounds
0.3×
Latest step-up
Top 25%
Sector rank · raised
Series A
Latest stage · inferred · Wed Jul 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)

Hygea Holdings Corp. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.63× the median modeled value of Series A Other Health Care companies in 2013–2015 (187 peers) — value vs value, same stage and era.
Dormant
  • Last raise 12.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Hygea Holdings Corp. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
56.5 yr record
Peak capital year was Undated with $4.3M across 1 filings.
Market position
ahead of 76% of Other Health Care peers
Capital scale is ahead of 76% of Other Health Care peers; modeled value is above 74% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in Undated: $4.3M across 1 filings.
  • Largest single filing was $4.3M on .
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Hygea Holdings Corp. is one of 5376 Other Health Care companies tracked from Doral. By capital raised it ranks in the upper tier (ahead of 76% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeries A · Raised $4.3M (real) Modeled valuation $10M (est)$4.3M$10MSeries APre-Seed · 2009-09-01 Raised $565K (real) Modeled valuation $17M (est)$565K$17MPre-Seed2009Pre-Seed · 2010-06-01 Raised $697K (real) Modeled valuation $21M (est)$697K$21MPre-Seed2010Pre-Seed · 2010-09-01 Raised $441K (real) Modeled valuation $14M (est)$441K$14MPre-Seed2010Seed · 2013-07-31 Raised $3.1M (real) Modeled valuation $76M (est)$3.1M$76MSeed2013Seed · 2013-07-31 Raised $1.1M (real) Modeled valuation $26M (est)$1.1M$26MSeed2013+$565K+$697K+$441K+$3.1M+$1.1MCumulative $10M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$4.3M
Bridge · Series A-stage$565K · 2009smaller follow-on
Bridge · Series A-stage$697K · 2010smaller follow-on
Bridge · Series A-stage$441K · 2010smaller follow-on
Bridge · Series A-stage$3.1M · 2013smaller follow-on
Bridge · Series A-stage$1.1M · 2013smaller follow-on

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$75.8M
Base estimate est.
$2.6M
Conservative case
$595.1M
Upside case
$15.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $10.2M · Pre-Seed · modeled $17.4M · 2009-09-01Pre-Seed · modeled $21.5M · 2010-06-01Pre-Seed · modeled $13.6M · 2010-09-01Seed · modeled $75.8M · 2013-07-31Seed · modeled $26.0M · 2013-07-312013
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
12.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
105 mo
Avg between rounds
$233K/yr
Capital velocity
56.5 yr
On record since
1970
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 4.2× above median
This company$10.1M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.2× of median
This company$1.1M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 3.4× above median
This company$75.8M
Sector median$22.1M

Raised more than 76% of sector peers (real $). Modeled value above 74% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #141 of 187.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Imagine Health, Inc. · Series A Raised $15.0M · modeled $302.7M (est)Inova Labs, Inc. · Series A Raised $32.6M · modeled $302.7M (est)Spruce Health, Inc. · Series A Raised $15.0M · modeled $302.7M (est)Cephea Valve Technologies, Inc. · Series A Raised $21.2M · modeled $296.8M (est)ClarVista Medical, Inc. · Series A Raised $14.5M · modeled $293.0M (est)Minimally Invasive Devices Inc. · Series A Raised $43.3M · modeled $284.9M (est)Osprey Medical Inc. · Series A Raised $14.0M · modeled $282.5M (est)IGeneX Group, LLC · Series A Raised $13.5M · modeled $273.4M (est)Urohsd, Llc · Series A Raised $13.2M · modeled $266.9M (est)Secure EDI Holdings, LLC · Series A Raised $28.3M · modeled $263.5M (est)Sterling Healthcare Holdings, Llc · Series A Raised $13.4M · modeled $259.1M (est)Wallick Senior Housing Holdings, LLC · Series A Raised $12.8M · modeled $259.1M (est)Hygea Holdings Corp. (this company) Raised $10.1M · modeled $75.8M (est)Hygea Holdings Corp.
CompanyStageRaised · realValue · estvs peer med.
Imagine Health, Inc.Series A$15.0M$302.7M2.50×
Inova Labs, Inc.Series A$32.6M$302.7M2.50×
Spruce Health, Inc.Series A$15.0M$302.7M2.50×
Cephea Valve Technologies, Inc.Series A$21.2M$296.8M2.46×
ClarVista Medical, Inc.Series A$14.5M$293.0M2.42×
Minimally Invasive Devices Inc.Series A$43.3M$284.9M2.36×
Osprey Medical Inc.Series A$14.0M$282.5M2.34×
IGeneX Group, LLCSeries A$13.5M$273.4M2.26×
Urohsd, LlcSeries A$13.2M$266.9M2.21×
Secure EDI Holdings, LLCSeries A$28.3M$263.5M2.18×
Sterling Healthcare Holdings, LlcSeries A$13.4M$259.1M2.14×
Wallick Senior Housing Holdings, LLCSeries A$12.8M$259.1M2.14×
Hygea Holdings Corp. this companySeries A$10.1M$75.8M0.63×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$565K2009-09-01$3.1M$17.4M90%
Pre-Seed$697K2010-06-01$3.9M$21.5M90%
Pre-Seed$441K2010-09-01$2.5M$13.6M90%
Seed$3.1M2013-07-31$15.3M$75.8M90%
Seed$1.1M2013-07-31$5.3M$26.0M90%
Series A$4.3M$19.6M$10.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$565K2009-09-01
    • First recorded raise — entered as Pre-Seed.
  2. Pre-Seed$697K2010-06-01
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  3. Pre-Seed$441K2010-09-01
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
  4. Seed$3.1M2013-07-31
    • Raised again after 35 mo — slower than the ~14 mo sector norm.
    • Round 6.9× larger than the prior — scaling up.
  5. Seed$1.1M2013-07-31
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.9× smaller than the prior — bridge or down round.
Intelligence
2022 ~Q2
Modeled next raise · ~105mo cadence
$1.1M
Modeled next size est.range $1.1M$1.7M
0.3×
Last step-up
$233K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Carl T. Rosencrantz2013-07
Daniel T. McGowan2013-07
Edward T. Moffly2013-07
Francisco T. Recio2013-07
Frank T. Kelley2013-07
Glenn T. Marrichi2013-07
Manuel Iglesias2013-07
Martha T. Castillo2013-07
Timothy Betts2009-09
Registry & provenance

Hygea Holdings Corp. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1469628
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
ProSomnus, Inc.Other Health CareSeries A$10.1M$64.4Msame sector · same stage
EGB VenturesOther Health CareSeries A$10.0M$62.6Msame sector · same stage
Ostial CorpOther Health CareSeries A$10.4M$71.6Msame sector · same stage
Acuity EyeCare Rollover II, LLCOther Health CareSeries A$9.8M$61.2Msame sector · same stage
Forward Health Group, Inc.Other Health CareSeries A$10.5M$81.1Msame sector · same stage
Valor Medical, Inc.Other Health CareSeries A$10.5M$82.3Msame sector · same stage
Compliant Innovations, IncOther Health CareSeries A$9.6M$88.1Msame sector · same stage
Omeza, LLCOther Health CareSeries A$10.8M$79.3Msame sector · same stage
Frequently asked
How much funding has Hygea Holdings Corp. raised?
Hygea Holdings Corp. has raised approximately $10.1M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is Hygea Holdings Corp.'s estimated valuation?
Provath's modeled valuation for Hygea Holdings Corp. is approximately $75.8M (modeled range $2.6M–$595.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Hygea Holdings Corp. at?
Hygea Holdings Corp.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Wed Jul 31.
What does Hygea Holdings Corp. do and where is it based?
Hygea Holdings Corp. operates in the Other Health Care sector, based in Doral.
Explore related

See where Hygea Holdings Corp. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Hygea Holdings Corp., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.